Published in J Virol on September 01, 1974
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Inhibition of host cell RNA polymerase III-mediated transcription by poliovirus: inactivation of specific transcription factors. Mol Cell Biol (1987) 1.29
An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID. Mol Cell Biol (1988) 1.24
Inhibition of basal transcription by poliovirus: a virus- encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J Virol (1996) 1.21
Viral RNA synthesis and levels of DNA-dependent RNA polymerases during replication of adenovirus 2. J Virol (1975) 1.18
Distinct molecular structures of nuclear class I, II, and III DNA-dependent RNA polymerases. Proc Natl Acad Sci U S A (1975) 1.17
DNA binding domain and subunit interactions of transcription factor IIIC revealed by dissection with poliovirus 3C protease. Mol Cell Biol (1996) 1.13
Inhibition of rRNA synthesis by poliovirus: specific inactivation of transcription factors. J Virol (1989) 1.13
Modification of RNA polymerase IIO subspecies after poliovirus infection. J Virol (1987) 0.86
Proteins solubilized from frog virus 3 particles: effect on transcription. J Virol (1976) 0.83
Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury. J Clin Invest (1993) 0.80
Modification of an adenovirus major late promoter-binding factor during poliovirus infection. J Virol (1989) 0.79
Phosphorylation-dephosphorylation of nuclear proteins during infection (Q fever). Infect Immun (1984) 0.79
Increased frequency of initiation of RNA synthesis due to a protein factor from chicken myeloblastosis nuclei. Proc Natl Acad Sci U S A (1975) 0.78
Multiple forms of DNA-dependent RNA polymerase in eukaryotic organisms. Nature (1969) 6.98
Effects on host cell metabolism following synchronous infection with poliovirus. Virology (1965) 4.88
Specific nucleolar and nucleoplasmic RNA polymerases. Proc Natl Acad Sci U S A (1970) 4.63
Patterns of macromolecular synthesis in normal and virus-infected mammalian cells. Cold Spring Harb Symp Quant Biol (1962) 4.49
The turnover of nuclear DNA-like RNA in HeLa cells. J Cell Biol (1968) 3.39
Encephalomyocarditis virus infection of mouse plasmacytoma cells. I. Inhibition of cellular protein synthesis. J Virol (1974) 3.28
Role of DNA-dependent RNA polymerase 3 in the transcription of the tRNA and 5S RNA genes. Proc Natl Acad Sci U S A (1974) 3.14
Products of RNA polymerases in HeLa cell nuclei. Proc Natl Acad Sci U S A (1971) 3.02
Multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in Xenopus laevis. Isolation and partial characterization. J Biol Chem (1974) 2.80
NUCLEIC ACID AND PROTEIN SYNTHESIS DURING POLIOVIRUS INFECTION OF HUMAN CELLS. J Mol Biol (1964) 2.10
Ribosomal RNA synthesis in isolated nuclei. J Mol Biol (1972) 2.03
The rapid turnover of RNA polymerase of rat liver nucleolus, and of its messenger RNA. Proc Natl Acad Sci U S A (1972) 1.98
Inhibition of RNA synthesis in HeLa and L cells by Mengovirus. Virology (1967) 1.54
Fate of mRNA of L-cells infected with mengovirus. J Virol (1974) 1.43
Inhibition of DNA-primed RNA synthesis during poliovirus infection of human cells. Biochem Biophys Res Commun (1962) 1.29
Mechanism of Mengo virus-induced cell injury in L cells: use of inhibitors of protein synthesis to dissociate virus-specific events. J Virol (1972) 1.29
Transcription of chromatin by bacterial RNA polymerase. J Mol Biol (1973) 1.28
Regulation of synthesis and processing of nucleolar components in metaphase-arrested cells. J Mol Biol (1971) 1.22
The effect of mengovirus infection on the activity of the DNA-dependent RNA polymerase of L-cells. II. Preliminary data on the inhibitory factor. Biochem Biophys Res Commun (1964) 1.19
Transcription of Xenopus chromatin by homologous ribonucleic acid polymerase: aberrant synthesis of ribosomal and 5S ribonucleic acid. Biochemistry (1974) 1.09
THE FATE OF RAPIDLY LABELLED RIBONUCLEIC ACID IN THE PRESENCE OF ACTINOMYCIN IN NORMAL AND VIRUS-INFECTED ANIMAL CELLS. Biochim Biophys Acta (1964) 0.97
HeLa cell nucleolar RNA synthesis after poliovirus infection. Virology (1973) 0.93
Cellular changes attending mengovirus-induced cytolysis of mouse L-cells. Biochim Biophys Acta (1971) 0.88
Differential inhibition of nuclear RNA polymerases in L cells infected with mengovirus. Proc Soc Exp Biol Med (1972) 0.82
Evidence for a cellular ribonucleic acid synthesis inhibitor from poliovirus-infected HeLa cells. Biochemistry (1971) 0.82
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA. Cell (1979) 19.98
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 16.79
Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell (1985) 13.36
Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates. J Biol Chem (1979) 11.68
Specific interaction of a purified transcription factor with an internal control region of 5S RNA genes. Cell (1980) 10.87
Multiple factors required for accurate initiation of transcription by purified RNA polymerase II. J Biol Chem (1980) 10.78
Multiple factors are required for the accurate transcription of purified genes by RNA polymerase III. J Biol Chem (1980) 10.63
Eukaryotic gene transcription with purified components. Methods Enzymol (1983) 9.71
Accurate transcription initiation on a purified mouse beta-globin DNA fragment in a cell-free system. Cell (1980) 8.02
Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell (1980) 7.42
Transcription of adenovirus type 2 genes in a cell-free system: apparent heterogeneity of initiation at some promoters. Mol Cell Biol (1981) 7.12
Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol Cell Biol (1983) 7.01
Multiple forms of DNA-dependent RNA polymerase in eukaryotic organisms. Nature (1969) 6.98
Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc Natl Acad Sci U S A (1985) 6.94
The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev (1990) 6.88
Transcription of class III genes: formation of preinitiation complexes. Science (1983) 6.79
Transcription of the beta-like globin genes and pseudogenes of the goat in a cell-free system. Nucleic Acids Res (1981) 6.63
DNA sequences affecting specific initiation of transcription in vitro from the EIII promoter of adenovirus 2. Proc Natl Acad Sci U S A (1982) 6.57
Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science (1970) 6.39
Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID. Mol Cell Biol (1988) 5.60
Myocarditis and cardiomyopathy associated with clozapine. Lancet (1999) 5.41
Biochemistry and structural biology of transcription factor IID (TFIID). Annu Rev Biochem (1996) 5.19
Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell (1987) 5.04
Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Crystal structure of TFIID TATA-box binding protein. Nature (1992) 4.85
Clinical utility of serum tests for iron deficiency in hospitalized patients. Am J Clin Pathol (1990) 4.76
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med (1999) 4.75
A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins. Proc Natl Acad Sci U S A (1988) 4.72
Specific nucleolar and nucleoplasmic RNA polymerases. Proc Natl Acad Sci U S A (1970) 4.63
ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors. J Biol Chem (1985) 4.62
Synergistic activation of transcription by CBP and p53. Nature (1997) 4.54
Endometriosis. N Engl J Med (1993) 4.38
Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A (1988) 4.33
Xenopus 5S gene transcription factor, TFIIIA: characterization of a cDNA clone and measurement of RNA levels throughout development. Cell (1984) 4.32
Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex. Cell (1988) 4.15
Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature (1991) 4.09
Inducible binding of a factor to the c-fos enhancer. Cell (1986) 3.98
Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J Biol Chem (1988) 3.96
A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature (1988) 3.95
Separation and partial characterization of three functional steps in transcription initiation by human RNA polymerase II. J Biol Chem (1985) 3.89
Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. J Biol Chem (1974) 3.84
Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc Natl Acad Sci U S A (1986) 3.81
Incommunicable knowledge: science, technology and the clinical art in Britain 1850-1914. J Contemp Hist (1985) 3.74
Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box. Nature (1989) 3.74
Structure and function of the b/HLH/Z domain of USF. EMBO J (1994) 3.70
Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 3.61
A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature (1991) 3.59
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Mol Cell Biol (1987) 3.52
Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science (1995) 3.50
Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res (1991) 3.48
Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell (1999) 3.47
The structure of the human histone genes: clustered but not tandemly repeated. Cell (1981) 3.47
Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell (1994) 3.43
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature (1990) 3.42
Physical analysis of transcription preinitiation complex assembly on a class II gene promoter. Science (1988) 3.40
Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE. J Biol Chem (1987) 3.38
Activation of class II gene transcription by regulatory factors is potentiated by a novel activity. Cell (1991) 3.36
Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A (1986) 3.34
Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol (2001) 3.31
Encephalomyocarditis virus infection of mouse plasmacytoma cells. I. Inhibition of cellular protein synthesis. J Virol (1974) 3.28
Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus. Cell (1985) 3.21
Characterization of a murine gene expressed from the inactive X chromosome. Nature (1991) 3.21
Family of proteins that interact with TFIID and regulate promoter activity. Cell (1991) 3.20
Mechanism of action of a yeast activator: direct effect of GAL4 derivatives on mammalian TFIID-promoter interactions. Cell (1988) 3.17
The binding of a transcription factor to deletion mutants of a 5S ribosomal RNA gene. Cell (1981) 3.15
Role of DNA-dependent RNA polymerase 3 in the transcription of the tRNA and 5S RNA genes. Proc Natl Acad Sci U S A (1974) 3.14
Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. Trends Biochem Sci (2000) 3.03
Control of transcription by Krüppel through interactions with TFIIB and TFIIE beta. Nature (1995) 2.96
Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci U S A (1974) 2.95
Functional steps in transcription initiation and reinitiation from the major late promoter in a HeLa nuclear extract. J Biol Chem (1987) 2.95
Formation of a rate-limiting intermediate in 5S RNA gene transcription. Cell (1985) 2.94
Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (1999) 2.93
Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature (1996) 2.92
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol (1991) 2.88
Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature (1994) 2.87
Activation of transcription factor IIIC by the adenovirus E1A protein. Cell (1988) 2.86
HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev (1992) 2.85
Multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in Xenopus laevis. Isolation and partial characterization. J Biol Chem (1974) 2.80
The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci U S A (1998) 2.76
Multiple factors involved in the transcription of class III genes in Xenopus laevis. J Biol Chem (1982) 2.75
Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol (1995) 2.74
A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol Cell (1999) 2.71
Phosphorylation of serum response factor, a factor that binds to the serum response element of the c-FOS enhancer. Proc Natl Acad Sci U S A (1988) 2.70
Multiple sequence elements are required for maximal in vitro transcription of a human histone H2B gene. Mol Cell Biol (1986) 2.69
Bleeding time. A guide to its diagnostic and clinical utility. Arch Pathol Lab Med (1989) 2.69
An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand (1992) 2.69
HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell (2000) 2.68
The ATP-dependent interaction of eukaryotic initiation factors with mRNA. J Biol Chem (1987) 2.65
Purification of the c-fos enhancer-binding protein. Mol Cell Biol (1987) 2.64
The pseudorabies immediate early protein stimulates in vitro transcription by facilitating TFIID: promoter interactions. Genes Dev (1988) 2.60
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
Structural similarity between TAFs and the heterotetrameric core of the histone octamer. Nature (1996) 2.58